Back
10x Genomics Vs. P3 Health Partners Industry Stock Comparison
Sell
33
TXG
10x Genomics
Last Price:
13.29
Seasonality Move:
18.49%
Sell
37
PIII
P3 Health Partners
Last Price:
0.22
Seasonality Move:
-49.43%
Sell
33
10x Genomics (TXG)
is a Sell
Is 10x Genomics a Buy, Sell or Hold?
- The current 10x Genomics [TXG] share price is $13.32. The Score for TXG is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- TXG is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
P3 Health Partners (PIII)
is a Sell
Is P3 Health Partners a Buy, Sell or Hold?
- The current P3 Health Partners [PIII] share price is $0.20. The Score for PIII is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- PIII is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TXG Stock Price Chart
What is 10x Genomics's stock price today?
-
The 10x Genomics share price today is $13.32
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TXG is experiencing slight selling pressure.
PIII Stock Price Chart
What is P3 Health Partners's stock price today?
-
The P3 Health Partners share price today is $0.20
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PIII is experiencing selling pressure, which indicates risk of future bearish movement.
TXG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.17 | Sell |
| Relative Strength Index (14 RSI): | 31.05 | Sell |
| Chaikin Money Flow: | -714082 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.29 - 16.49) | Sell |
| Bollinger Bands (100): | (16.23 - 22.05) | Sell |
PIII Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 28.09 | Sell |
| Chaikin Money Flow: | -934413 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.27 - 0.43) | Sell |
| Bollinger Bands (100): | (0.35 - 0.57) | Sell |
TXG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.26 | Sell |
| 20-day SMA: | 15.4 | Sell |
| 50-day SMA: | 18.06 | Sell |
| 200-day SMA: | 25.72 | Sell |
| 8-day EMA: | 14.12 | Sell |
| 20-day EMA: | 15.25 | Sell |
| 50-day EMA: | 17.23 | Sell |
| 200-day EMA: | 25.17 | Sell |
PIII Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.26 | Sell |
| 20-day SMA: | 0.33 | Sell |
| 50-day SMA: | 0.38 | Sell |
| 200-day SMA: | 0.61 | Sell |
| 8-day EMA: | 0.25 | Sell |
| 20-day EMA: | 0.31 | Sell |
| 50-day EMA: | 0.37 | Sell |
| 200-day EMA: | 0.69 | Sell |
10x Genomics Earnings Growth & TXG Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and an increase next year of $0.05 per share.
P3 Health Partners Earnings Growth & PIII Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.30 per share, and an increase next year of $0.42 per share.
10x Genomics Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
P3 Health Partners Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||